← Back to Search

Individuals given Standard Bolus first, then quick bolus for Type 1 Diabetes

N/A

Waitlist Available

Led By Eda Cengiz, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 300 minutes

Awards & highlights

Study Summary

This trial looks at how quickly insulin works in the body.

Eligible Conditions

Type 1 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 300 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~300 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 300 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time to Maximum Glucose Infusion Rate

Secondary outcome measures

Area Under the Curve for the Glucose Infusion Rate

Earlier Clearance of Exogenous Insulin.

Maximum Glucose Infusion Rate

Trial Design

2Treatment groups

Active Control

Group I: Individuals given Standard Bolus first, then quick bolusActive Control2 Interventions

Individuals with Type 1 Diabetes (T1D) will receive both Standard and Quick Bolus in a randomized cross-over design.

Group II: Individuals given Quick bolus first, then standard bolusActive Control2 Interventions

Individuals with Type 1 Diabetes (T1D) will receive both Standard and Quick Bolus in a randomized cross-over design.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,848 Previous Clinical Trials

2,737,807 Total Patients Enrolled

Eda Cengiz, MDPrincipal InvestigatorYale University

3 Previous Clinical Trials

63 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to enroll in this experiment?

"Potential enrollees must have diabetes mellitus and be between 18-30 years old to qualify for this trial. The total number of participants being sought is 15 individuals."

Answered by AI

What is the current size of this research cohort?

"Affirmative. The information on clinicaltrials.gov attests to the fact that this research trial, which had its initial post date of May 30th 2018, is currently accepting applicants. A total of 15 participants need to be recruited from 1 medical centre."

Answered by AI

Does this clinical research accept participants who are 25 years or older?

"This clinical trial has a limit of 30 years when it comes to enrolling participants; any patient younger than 18 and older than 30 won't be accepted."

Answered by AI

Are participants being actively sought for this trial?

"As noted on clinicaltrials.gov, this research is currently recruiting participants. The trial was first publicly shared on May 30th 2018 and most recently updated on January 7th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes

2018. "The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03542682.